Search

everythinglearnresearchcommunity

for

Search:↓

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Group a wide range of chemicals, not just phthalates, for assessing risks to male reproductive health.

Some alternative treatments for hair loss might work, but more research is needed.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Growing hair follicles have high mitochondrial activity and ROS in specific regions, aiding hair formation.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Vitamin D3 analogs can promote hair growth in mice genetically prone to hair loss.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Accurate clinical, histological, and genetic methods are key for understanding and treating hair disorders.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Mice skin has components that could help with hair growth and might be used for diabetes treatment.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

LEF1 interacts with Vitamin D Receptor, affecting hair follicle regeneration and this could be linked to hair loss conditions.

Food deprivation increases MST enzyme in the brain, possibly affecting energy balance.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Manage hair shedding by identifying triggers, possibly using supplements or medications, and tracking with a health calendar.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Finasteride reduces hair growth and is safe for women with excessive hair.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Caffeine applied to the scalp can protect hair follicles from UV damage.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.